New Research Shows Effectiveness of Light Disinfection Against COVID-19

Technology also proven to work against Influenza A

By HFT Editorial Staff


Newly published research shows that light disinfection technology effectively and safely inactivates SARS-CoV-2 and influenza A viruses in a range of real-world clinical settings.

The paper, "The virucidal effects of 405 nm visible light on SARS-CoV-2 and influenza A virus," was published in Scientific Reports on September 30, 2021. It reflects how researchers evaluated the inactivation rate of the SARS-CoV-2 virus using 405 nm visible light under a range of clinical conditions. By applying these findings to a real-world usage model, it is determined that the technology would achieve a SARS-CoV-2 inactivation rate of 94 percent based on 12 hours of occupied room use and 12 hours of unoccupied room use.

The potential of specific wavelengths within the electromagnetic spectrum is an area of growing clinical interest. Ultraviolet (UV) technologies have demonstrated the ability to reduce virological spread, but potential toxicities have limited its use in occupied spaces. Longer wavelengths with less irradiation energy such as visible light (405 nanometers) have largely been evaluated in bactericidal and fungicidal applications. This research offers some of the strongest evidence to date of the real-world application of 405 nm visible light to inactivate the SARS-CoV-2 and influenza A viruses, helping to create safe, occupied spaces.

"Reducing the ability of SARS-CoV-2 and influenza A to spread within healthcare settings is paramount," says Adolfo Garcia-Sastre, Ph.D., Director of the Global Health & Emerging Pathogens Institute and Professor of Microbiology and Medicine at the Icahn School of Medicine at Mount Sinai and the study's lead investigator. "This research adds important findings to the medical literature. It shows the potential of a simple, non-invasive technological solution to achieve inactivation of these highly disruptive viruses and warrants further evaluation across a range of additional clinical settings to further validate its effectiveness and safety."

The research was published from a partnership between Kenall and the Icahn School of Medicine at Mount Sinai.



October 6, 2021


Topic Area: Infection Control


Recent Posts

Seeking Standards for Microbial Loads in Healthcare Facilities

Why is there no binding standard for the acceptable microbial load on surfaces or in the air in hospitals?


UCR Health Unveils Plans for Major Expansion

The vision for the site will include an outpatient diagnostic center and possible future expansion.


High-Performance Windows Support Safety at UW Medicine's New Behavioral Health Center

Case study: Engineered for strength, quiet and daylight, the chosen windows help create a safe, calming and energy-efficient environment for patients and providers.


Central Maine Healthcare Dealing with IT System Outage

The organization identified unusual activity within their computer software, prompting them to secure and shut off all IT systems.


Kaiser Permanente Opens Newly Expanded Everett Medical Center

The facility offers primary care and pediatric care and has specialty care departments.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.